Large-Scale Validation of a Flow Cytometry Platform for Comprehensive Immunophenotyping, Cell Size Determination, and Prognostic Stratification in Canine Lymphomas
Boosting the power of AI-based treatment outcome predictions for canine lymphoma by combining tumor and germline genetic biomarkers and live-cell analytics
Dramatically increased clinical remission rates and survival times in dogs with high-grade T-cell lymphoma and relapsed B-cell lymphoma in clinical study of AI decision support